Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial.
Matthew J FerrisWilliam C SpanosRom S LeidnerAnthony GonçalvesUwe M MartensChrisann KyiWilliam SharfmanChristine H ChungLot A DevrieseHelene GauthierSimon I ChioseaLazar VujanovicJanis M TaubeJulie E SteinJun LiBin LiTian ChenAdam BarrowsSuzanne L TopalianPublished in: Journal for immunotherapy of cancer (2021)
ClinicalTrials.gov NCT02488759; https://clinicaltrials.gov/ct2/show/NCT02488759.